| Financial Year |
March 31 2023 |
| Monetary Funds |
10,681,709,584.42 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
278,144.44 |
| Accounts Receivable |
19,603,770,071.89 |
| Advances to Suppliers |
125,732,514.56 |
| Other Receivables |
327,160,987.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
587,684,228.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
552,826,275.47 |
| Total Current Assets |
31,879,161,806.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
67,950,510,377.22 |
| Investment Properties |
96,657,190.57 |
| Fixed Assetes |
445,664,890,267.13 |
| Under-construction Projects |
3,987,617,251.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
21,908,758,521.20 |
| R&D expenses |
90,768,249.91 |
| Goodwill |
1,066,690,110.61 |
| Long-Term Deferred and Prepaid Expenses |
55,533,966.62 |
| Deferred Income Tax Assets |
420,783,494.25 |
| Other Non-Current Assets |
245,690,763.25 |
| Sub-Total of Non-Current Assets |
548,120,987,424.59 |
| Total Assets |
580,000,149,231.43 |
| Short-Term Loans |
71,840,853,921.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,482,159.19 |
| Accounts Payable |
1,012,782,231.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
328,955,799.19 |
| Taxes Payable |
2,235,170,858.14 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
31,542,974,063.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
32,258,864,464.23 |
| Other Current Liabilities |
13,749,239,308.68 |
| Sub-Total of Current Liabilities |
153,000,443,693.02 |
| Long-term Loans |
193,406,613,751.00 |
| Bonds Payable |
35,439,787,340.99 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
50,595,740.61 |
| Deferred Income Tax Liabilities |
2,309,396,827.68 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
231,841,847,438.00 |
| Total Liabilities |
384,842,291,131.02 |
| Paid-In Capital(Or Share Stock) |
23,663,781,655.00 |
| Capital Surplus |
49,069,274,456.57 |
| Surplus Reserve |
24,967,736,455.15 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
85,487,999,562.55 |
| Minority Stockholder's Interest |
10,379,614,196.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
184,778,243,903.76 |
| Owner's Equity（Stockholder's Equity） |
195,157,858,100.41 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
580,000,149,231.43 |
